Grobler A, Cawood C, Khanyile D, Puren A, Kharsany ABM.
Lancet HIV 2017; 4(11):e505-e513.
Mngadi KT, Singh JA, Mansoor LE, Wassenaar DR.
Journal of Medical Ethics 2017; 43(12):824-828.
Garrett N, Norman E, Leask K, Naicker N, Asari V, Majola N, Abdool Karim Q, and Abdool Karim SS.
AIDS and Behavior 2017. DOI: 10.1007/s10461-017-1729-2.
Dorward J, Mabuto T, Charalambous S, Fielding KL, Hoffmann CJ.
JAIDS 2017; 76(5):453-460.
Mitchell EMH, Daftary A.
International Journal of Tuberculosis and Lung Disease 2017; 21(11): S1. doi: 10.5588/ijtld.17.0651.
Leitman EM, Thobakgale CF, Adland E, Ansari MA, Raghwani J, Prendergast AJ, Tudor-Williams G, Kiepiela P, Hemelaar J, Brener J, Tsai MH, Mori M, Riddell L, Luzzi G, Jooste P, Ndung'u T, Walker BD, Pybus OG, Kellam P, Naranbhai V, Matthews PC, Gall A, Goulder PJR.
Journal of Experimental Medicine 2017; 214(11):3239-3261.
CAPRISA was created in 2001 and formally established in 2002 under the NIH-funded Comprehensive International Program of Research on AIDS (CIPRA) by five partner institutions; University of KwaZulu-Natal, University of Cape Town, University of Western Cape, National Institute for Communicable Diseases, and Columbia University in New York. CAPRISA is a designated UNAIDS Collaborating Centre for HIV Prevention Research. The main goal of CAPRISA is to undertake globally relevant and locally responsive research that contributes to understanding HIV pathogenesis, prevention and epidemiology as well as the links between tuberculosis and AIDS care.